Eupraxia Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Related People
Fund Service Providers
Startup & Company Raises
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Eupraxia Pharmaceuticals Inc
TickerEPRX
CIK #0001581178
CUSIP29842P105
SectorLife Sciences - Pharmaceutical Preparations
Address201-2067 Cadboro Bay Rd, Victoria, BC V8R 5G4
Source [EDGAR]
CIK Filing 2011 - 2026
[0001581178] 6-K
[0001581178] D
[0001581178] SC 13D
[0001581178] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Disbrow Robert Eupraxia Pharmaceuticals Inc [2024-11-14] 8.6
Freedman Joseph S Eupraxia Pharmaceuticals Inc [2024-11-07] 12.4
Form 13F Holdings
Firm Period DFND Voting Shares
Scotia Capital Inc [2025-06-30] DFND 0 1,291,989
Royal Bank of Canada [2025-06-30] DFND 292,384 428,584
Goldman Sachs Group Inc [2025-06-30] DFND 39,800 39,800
UBS Group AG [2025-06-30] DFND 0 37,499
Bank of Montreal /Can/ [2025-06-30] DFND 37,250 37,250
Ingalls & Snyder LLC [2025-06-30] OTR 0 37,200
JPMorgan Chase & Co [2025-06-30] DFND 18,717 18,717
Citadel Advisors LLC [2025-06-30] DFND 18,236 18,236
CIBC World Market Inc [2025-06-30] SOLE 15,000 15,000
Bank of America Corp /DE/ [2025-06-30] DFND 12,300 12,559
Raymond James Financial Inc [2025-06-30] DFND 0 12,212
Quadrature Capital Ltd [2025-06-30] OTR 0 10,700
TD Waterhouse Canada Inc. [2025-06-30] DFND 9,600 9,600
National Bank of Canada /FI/ [2025-06-30] DFND 0 730
Concourse Financial Group Securities Inc [2025-06-30] SOLE 0 0
Prev | Page 9 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com